Catalyst Biosciences Stock Price

0.03 (2.54%)
Upgrade to Real-Time
Regular Market
Volume 749,246
Bid Price 1.21
Ask Price 1.22
News -
Day High 1.28


52 Week Range


Day Low 1.16
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalyst Biosciences Inc CBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 2.54% 1.21 15:33:28
Open Price Low Price High Price Close Price Prev Close
1.20 1.16 1.28 1.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,561 749,246 $ 1.23 $ 923,717 - 1.04 - 7.55
Last Trade Time Type Quantity Stock Price Currency
15:33:28 100 $ 1.21 USD


Draw Mode:

Catalyst Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.25M 30.78M 31.27M $ 20.95M $ - -2.85 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 45.09k 1.60%

more financials information »

Catalyst Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,7170.010.83%
1 Month3.,176,958-1.80-59.8%
3 Months4.785.201.042.47626,100-3.57-74.69%
6 Months4.335.201.043.19456,640-3.12-72.06%
1 Year6.147.551.044.42422,417-4.93-80.29%
3 Years10.2211.971.045.79312,779-9.01-88.16%
5 Years10.2037.001.048.84377,680-8.99-88.14%

Catalyst Biosciences Description

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Your Recent History
Catalyst B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.